A detailed history of Alerus Financial Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Alerus Financial Na holds 20,507 shares of LLY stock, worth $16.3 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
20,507
Previous 21,788 5.88%
Holding current value
$16.3 Million
Previous $19.7 Million 7.9%
% of portfolio
1.39%
Previous 1.53%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $989,111 - $1.23 Million
-1,281 Reduced 5.88%
20,507 $18.2 Million
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $817,653 - $1.03 Million
-1,128 Reduced 4.92%
21,788 $19.7 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $544,824 - $728,897
-920 Reduced 3.86%
22,916 $17.8 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $3.28 Million - $3.87 Million
6,246 Added 35.51%
23,836 $13.9 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $2.11 Million - $2.91 Million
-4,862 Reduced 21.66%
17,590 $9.45 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $242,361 - $324,065
-691 Reduced 2.99%
22,452 $10.5 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $265,278 - $311,556
854 Added 3.83%
23,143 $7.95 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $689,724 - $803,667
2,145 Added 10.65%
22,289 $8.15 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.83 Million - $3.22 Million
9,538 Added 89.93%
20,144 $6.51 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $614,599 - $721,630
-2,205 Reduced 17.21%
10,606 $3.44 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $61,254 - $76,123
261 Added 2.08%
12,811 $3.67 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $840,489 - $1.04 Million
-3,738 Reduced 22.95%
12,550 $3.47 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $387,800 - $477,242
-1,750 Reduced 9.7%
16,288 $3.76 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $697,825 - $902,632
3,865 Added 27.27%
18,038 $4.14 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $1.63 Million - $2.11 Million
-9,902 Reduced 41.13%
14,173 $2.65 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $142,984 - $189,202
-1,096 Reduced 4.35%
24,075 $4.07 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $2.51 Million - $2.9 Million
17,153 Added 213.93%
25,171 $3.73 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $1.09 Million - $1.32 Million
8,018 New
8,018 $1.32 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alerus Financial Na Portfolio

Follow Alerus Financial Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.